Clinical Trials Logo

Clinical Trial Summary

Prospective, randomized, multinational, multicenter, double-blind trial in 2 parallel groups of patients


Clinical Trial Description

This study is a prospective, randomized, multinational, multicenter, double-blind trial in 2 parallel groups of patients. Patients will undergo screening examinations at Visit 1. Patients who meet all of the inclusion and none of the exclusion criteria will be randomized to double-blind treatment with one of the following: - Group A: Acetylcysteine/Paracetamol/Phenylephrine: one sachet three times per day OR - Group B: Paracetamol/Phenylephrine 500 mg/10 mg granules for oral solution: one sachet three times per day. A control visit (Visit 2) is planned on Day 3 of treatment. After the end of the double-blind treatment phase, the patients will undergo an end-of-treatment (EOT) examination at Visit 3 on Day 6. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05070650
Study type Interventional
Source Sandoz
Contact Novartis Pharmaceuticals
Phone +41-61-3241111
Email [email protected]
Status Not yet recruiting
Phase Phase 3
Start date October 29, 2021
Completion date May 25, 2022

See also
  Status Clinical Trial Phase
Completed NCT02451163 - DBRCT on the Effect of Wheat Polysaccharides on Common Cold Infections in Elderly Phase 2
Completed NCT01944631 - Iota-Carrageenan Nasal Spray in Common Cold Phase 4
Completed NCT01651715 - Efficacy and Safety Study of Homeopathic Oral Antibodies to Treat Viral Upper Respiratory Tract Infections Phase 1/Phase 2
Completed NCT00963443 - Acetylsalicylic Acid Combined With Pseudoephedrine in Common Cold Phase 3
Completed NCT00778648 - Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms N/A
Completed NCT00065715 - Echinacea Versus Placebo Effect in Common Cold (Physician Echinacea Placebo) Phase 3
Completed NCT00032500 - Evaluation of Echinacea for the Common Cold Phase 2
Completed NCT04144491 - Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in Uganda N/A
Not yet recruiting NCT04073511 - Herbal Medicine 'Eungyosan' and 'Samsoeum' for Common Cold N/A
Completed NCT03189537 - Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections Phase 3
Not yet recruiting NCT05034328 - Symbiofilm Trial in Allergic Kids (SYMBIOFILM-TAK)
Terminated NCT01964885 - Benefit and Tolerability of IQP-AS-105 in Reducing Susceptibility to Upper Respiratory Tract Infections Phase 3
Completed NCT01277081 - Effect of Paracetamol on the Common Cold Phase 2
Completed NCT01728090 - Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections Phase 4
Completed NCT00405509 - The Natural History of Viral Upper Respiratory Infections in Children Aged 6 to Less Than 14 Years N/A
Completed NCT01033526 - Symptomatic Treatment of Common Cold Symptoms Phase 4
Terminated NCT03339726 - Randomized, Double-blind, Placebo-Controlled, Efficacy Study of a New Formulation of Phenylephrine HCL in the Common Cold Phase 2
Completed NCT01459952 - A Double-blind, Randomised, Parallel Group,Comparative Study With Rose-hip Liquid and Placebo Given to Healthy Volunteers in the Winter Season Aiming to Evaluate the Occurences of Flu and Catching a Cold Phase 3
Completed NCT01686646 - Effects of Two Doses of a Common Cold Treatment on Alertness Phase 3
Completed NCT00552981 - Effectiveness of Local Application of Warm Air in Patients With Common Cold (HELI Study) N/A